• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • Opinion
    • International AIDS Conference

    Funding the end of an epidemic: #WhyNow?

    With the International AIDS Conference next week, True Claycombe from Friends of the Global Fight discusses the progress made in the fight against HIV/AIDS to date, where funding for the fight stands today, and why now is the time to move the fight forward.

    By True Claycombe // 14 July 2016
    Frank, a Tingathe community health worker, explains the results of a HIV test to a couple expecting their first child at the Kawale health center in Lilongwe, Malawi. Photo by: Robbie Flick / Baylor College of Medicine Children's Foundation - Malawi / CC BY-NC-ND

    HIV/AIDS is a crisis that we must continue to fight, both around the world and in the United States. Younger generations lack an understanding of this crisis, as they did not witness the thousands of devastating HIV/AIDS deaths throughout the United States in the 1980s and 1990s.

    Significant progress has been made, but those efforts are not enough — without careful decision-making and steady investments in the HIV/AIDS fight over the coming months and years, we stand to not only lose the gains made to date, but miss an opportunity to see the end of AIDS in our lifetimes.

    Progress in the fight against HIV/AIDS to date

    The ruthless disease that infiltrated U.S. communities during the early years of the HIV/AIDS crisis fueled an aggressive response by the U.S. government both nationally and globally. In 1990, with bipartisan support, Congress passed the Ryan White Comprehensive AIDS Resources Emergency Act, which was and is the largest federal program focused exclusively on providing HIV care and treatment services to people living with HIV in the United States.

    The President’s Emergency Plan for AIDS Relief and the Global Fund to Fight AIDS, Tuberculosis and Malaria were created in the early 2000s to combat the epidemic on a global scale.

    Globally, these efforts have been successful in averting 8.8 million deaths; however, we must aggressively continue fighting because people are still dying from HIV/AIDS (an estimated 1.2 million in 2014 alone).

    Additionally, there are currently 90 million people worldwide that still do not know if they have HIV, and an estimated 50 percent of people living with HIV are not receiving treatment or care. We — the global community — have the ability to save 21 million lives and prevent 28 million new HIV infections by 2030 if we act now.

    Where funding to fight HIV/AIDS stands today

    We must continue to draw the world’s attention to the HIV/AIDS crisis. This is a big year — and a historic opportunity — to win the fight and save lives. World leaders came to New York for the High-Level Meeting on Ending AIDS on June 8, 2016, and committed to the Political Declaration on Ending AIDS, which includes specific, time-bound targets that must be met in order to end the HIV/AIDS epidemic by 2030.

    In order to accomplish this, world leaders agreed to the UNAIDS Fast-Track approach which outlines the ambitious 90-90-90 plan: 90 percent of all people living with HIV to know their status; 90 percent of all people diagnosed with HIV to receive sustained antiretroviral therapy; and 90 percent of all people receiving antiretroviral therapy to have viral suppression.

    During the HLM, major announcements were made in support of ending the epidemic by 2030. The United States announced the launch of a new $100 million Key Populations Investment Fund to increase HIV services for key populations.

    Key populations include women and girls, men who have sex with men, and other subpopulations of individuals who are most vulnerable to HIV/AIDS. While this was a win in many ways in the fight against HIV/AIDS, we still have major gaps in financing. In the Political Declaration, world leaders called for relevant stakeholders to fund the gap in resources for HIV/AIDS, but an answer to the question of how exactly it will be financed remains vague.

    Why now is the time to move the fight forward

    In order to reach the goal of 90-90-90 by 2020, $26 billion a year is needed. This funding will be a combination of public and private investments, from increases in domestic financing from implementing countries, and donors like the Global Fund, PEPFAR and UNAIDS. The Global Fund set a target of raising $13 billion in its next three-year (2017-2019) cycle of funding. The Global Fund’s Investment Case outlines that this $13 billion could save 8 million lives, avert up to 300 million new infections across all three diseases, and lead to up to $290 billion in economic gains in countries where the Global Fund invests.

    “We have a tremendously important opportunity with the replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria. We need to look at the needs, estimate budgets based on those needs and then mobilize resources. Everything should be driven by the analytics.”

    — Jeffrey Sachs, director, Earth Institute, Columbia University

    However, some critics (such as Jeffrey Sachs) have claimed that the Global Fund’s target is too low, and that the HIV/AIDS community is overestimating how much will actually come from domestic financing. While it is not reasonable to completely discount domestic financing, we must be realistic in order for donor governments, including the United States, to continue to finance the fight.

    With substantial support from the American taxpayer, the U.S. government has committed more than $57 billion to bilateral HIV/AIDS programs and $13 billion to the Global Fund from 2004-2014. The United States is the number one donor to the Global Fund and essentially sets the benchmark for what other countries are willing to commit. Thus, the United States must continue its leadership role in the fight against HIV/AIDS. #WhyNow? Because with continued and robust investments, we have an opportunity to be the generation that put an end to the epidemic and saved 21 million lives worldwide.

    Join the Devex community and access more in-depth analysis, breaking news and business advice — and a host of other services — on international development, humanitarian aid and global health.

    • Global Health
    • Funding
    • Humanitarian Aid
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
    The views in this opinion piece do not necessarily reflect Devex's editorial views.

    About the author

    • True Claycombe

      True Claycombe

      True Claycombe is the policy manager at Friends of the Global Fight. In this role, she advocates for Friends’ legislative goals and provides research and analysis on major policy issues and external reports as they relate to the Global Fund, the three diseases, and global health more generally. True earned her M.A. in international development from American University. Before graduate school, she spent more than two years on Capitol Hill as a legislative assistant to Rep. David McKinley.

    Search for articles

    Related Stories

    Global healthOpinion: The next US administration's legacy can be to end HIV worldwide

    Opinion: The next US administration's legacy can be to end HIV worldwide

    Devex NewswireDevex Newswire: How to prepare for Trump’s foreign aid freeze

    Devex Newswire: How to prepare for Trump’s foreign aid freeze

    Global healthUSAID funding cuts jeopardize breakthrough drugs and research

    USAID funding cuts jeopardize breakthrough drugs and research

    Global HealthOpinion: The case for PEPFAR to push for country ownership in HIV response

    Opinion: The case for PEPFAR to push for country ownership in HIV response

    Most Read

    • 1
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 2
      How AI-powered citizen science can be a catalyst for the SDGs
    • 3
      Opinion: The missing piece in inclusive education
    • 4
      Opinion: India’s bold leadership in turning the tide for TB
    • 5
      Strengthening health systems by measuring what really matters
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement